⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT July 27, 2026

Candesartan/HCT 1A Pharma 8 mg/12,5 mg - Tabletten 8 mg/12,5 mg (Tablette)

📷 Wikipedia: Hydrochlorothiazide · Source
Candesartan/HCT 1A Pharma 8 mg/12,5 mg - Tabletten 8 mg/12,5 mg (Tablette)
📷 Wikipedia: Hydrochlorothiazide · Source
Candesartan/HCT 1A Pharma 8 mg/12.5 mg tablets are unavailable since 27 July 2026.
✅
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 47 days ago.
📈 Timeline
25 days in total
July 28, 2026 August 22, 2026

What is this? This is a tablet that contains two medicines: candesartan and hydrochlorothiazide. It is used for blood pressure.

What's happening? The tablets are not available in Austria right now. They ran out on 27 July 2026.

Does this affect me? If you take this exact tablet, you may not be able to get it until it is back in stock.

What should I do? Ask your pharmacist or doctor for another medicine that works the same. Do not stop taking your blood-pressure medicine without advice.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Agency-published detail

ATC: C09DA06 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: 1 A Pharma GmbH, Jakov-Lind-Straße 5/3.05, 1020 Wien, Österreich · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-07-27]

First published
July 27, 2026
Last refreshed by us
2 weeks ago
Severity (as classified)
Low
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Low AT 2 days ago

Valsartan/HCT 1A Pharma 160 mg/12,5 mg - Filmtabletten 160 mg/12,5 mg (Filmtablette)

Valsartan/HCT 1A Pharma 160 mg/12.5 mg film-coated tablets are unavailable due to manufacturing capacity issues.
Low AT 4 days ago

Candecam 8 mg/5 mg Tabletten 8/5 mg/mg (Tablette)

ATC: C09DB07 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: HCS B.V., Hendrik Kennisstraat 53, 2650 Edegem, Kingdom of Belgium · Affected packs: 28 Stück Schachtel, Bliste...
Low AT 4 days ago

Lisinopril-HCT ratiopharm - Tabletten (Tablette)

🚫 Parallel export ban active · ATC: C09BA03 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Niederlande · Affected packs: 30 Stück...
Low AT 4 days ago

Ramipril-HCT ratiopharm 2,5 mg/ 12,5 mg - Tabletten 2,5 mg/12,5 mg (Tablette)

ATC: C09BA05 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Niederlande · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht...
Low AT 4 days ago

Amlodipin/Valsartan/Hydrochlorothiazid ratiopharm 5 mg/160 mg/12,5 mg Filmtabletten 5/160/12,5 mg (Filmtablette)

ATC: C09DX01 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Niederlande · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht...
Low AT 1 week ago

Amlodipin/Valsartan/HCT Sandoz 5 mg/160 mg/25 mg – Filmtabletten 5/160/25 mg (Filmtablette)

Parallel export is banned for this medicine. It is unavailable due to manufacturing capacity shortages.
Low AT resolved 3 weeks ago

Ramipril/HCT Hexal 5 mg/25 mg - Tabletten 5 mg/25 mg (Tablette)

Ramipril/HCT Hexal 5 mg/25 mg tablets are currently unavailable due to manufacturing capacity issues.
Low AT resolved 3 weeks ago

Ramipril/HCT 1A Pharma 5 mg/25 mg - Tabletten 5 mg/25 mg (Tablette)

Ramipril/HCT 1A Pharma 5 mg/25 mg tablets are unavailable due to manufacturing capacity issues.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Candesartan/HCT 1A Pharma 8 mg/12,5 mg - Tabletten 8 mg/12,5 mg (Tablette). Candesartan/HCT 1A Pharma 8 mg/12.5 mg tablets are unavailable since 27 July 2026.
▸ When was this alert issued?
This alert was issued on July 27, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Low risk. A low risk means harm is unlikely under normal use. The alert is informational but still worth reading.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.